Emerson Electric Co. (EMR) Reports In-Line Q3 EPS; Affirms Outlook
Tweet
Share
E-mailGet Alerts EMR Hot Sheet
Price: $110.04 +0.21%
Revenue Growth %: +14.1%
Financial Fact:
Cost of sales: -530M
Today's EPS Names:
ESCA, LICT, NKSH, More
Revenue Growth %: +14.1%
Financial Fact:
Cost of sales: -530M
Today's EPS Names:
ESCA, LICT, NKSH, More
Join SI Premium – FREE
Emerson Electric Co. (NYSE: EMR) reported Q3 EPS of $0.90, in-line with the analyst estimate of $0.90. Revenue for the quarter came in at $6.29 billion versus the consensus estimate of $6.39 billion.
Affirms outlook.
Affirms outlook.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Equifax (EFX) shares tumble on weak Q1 revenue, guidance miss
- S&T Bancorp (STBA) Tops Q1 EPS by 3c
- Emerson's Next-Generation Software Streamlines Pharmaceutical Development, Accelerates Speed to Market
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
